Prothena Corporation plcProthena Corporation plcProthena Corporation plc

Prothena Corporation plc

No trades
See on Supercharts
Market capitalization
‪1.14 B‬USD
−2.77USD
‪−147.03 M‬USD
‪91.37 M‬USD
‪46.39 M‬
Beta (1Y)
0.73

About Prothena Corporation plc

CEO
Gene G. Kinney
Headquarters
Dublin
Employees (FY)
173
Founded
1969
ISIN
IE00B91XRN20
FIGI
BBG003PDKJF7
Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm’s clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PRTA is 21.10 USD — it has decreased by 0.89% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Prothena Corporation plc stocks are traded under the ticker PRTA.
Prothena Corporation plc is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
PRTA stock is 3.56% volatile and has beta coefficient of 0.73. Check out the list of the most volatile stocks — is Prothena Corporation plc there?
PRTA earnings for the last quarter are 0.38 USD per share, whereas the estimation was −0.32 USD resulting in a 217.73% surprise. The estimated earnings for the next quarter are −1.18 USD per share. See more details about Prothena Corporation plc earnings.
Prothena Corporation plc revenue for the last quarter amounts to ‪84.87 M‬ USD despite the estimated figure of ‪41.69 M‬ USD. In the next quarter revenue is expected to reach ‪2.15 M‬ USD.
Yes, you can track Prothena Corporation plc financials in yearly and quarterly reports right on TradingView.
PRTA stock has fallen by 2.63% compared to the previous week, the month change is a 16.99% fall, over the last year Prothena Corporation plc has showed a 61.62% decrease.
PRTA net income for the last quarter is ‪−67.48 M‬ USD, while the quarter before that showed ‪21.91 M‬ USD of net income which accounts for −408.01% change. Track more Prothena Corporation plc financial stats to get the full picture.
Today Prothena Corporation plc has the market capitalization of ‪1.14 B‬, it has decreased by 1.89% over the last week.
No, PRTA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PRTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Prothena Corporation plc stock right from TradingView charts — choose your broker and connect to your account.
PRTA reached its all-time high on Sep 27, 2021 with the price of 79.75 USD, and its all-time low was 5.64 USD and was reached on Jan 18, 2013.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 173.00 employees. See our rating of the largest employees — is Prothena Corporation plc on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Prothena Corporation plc technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Prothena Corporation plc stock shows the sell signal. See more of Prothena Corporation plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Prothena Corporation plc future price: according to them, PRTA price has a max estimate of 94.00 USD and a min estimate of 34.00 USD. Read a more detailed Prothena Corporation plc forecast: see what analysts think of Prothena Corporation plc and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Prothena Corporation plc EBITDA is ‪−170.88 M‬ USD, and current EBITDA margin is −199.87%. See more stats in Prothena Corporation plc financial statements.